PS04.04 the Use of Blood-Based Molecular Profiles to Monitor for Minimal Residual Disease or Recurrence After Surgical Resection

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2017.09.073
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Immunological and Molecular Correlates of Disease Recurrence After Liver Resection for Hepatocellular Carcinoma

PLoS ONE
Multidisciplinary
2012English

Editorial: Predicting Recurrence of Crohn's Disease After Surgical Resection-Close to a Crystal Ball. Authors’ Reply

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Factors Predicting Early Recurrence After Surgical Resection of Hepatocellular Carcinoma

Journal of Hepatology
Hepatology
2019English

Minimal Residual Disease

Leukemia Supplements
2012English

Minimal Residual Disease

Bone Marrow Transplantation
TransplantationHematology
2001English

Minimal Residual Disease Testing After Stem Cell Transplantation for Multiple Myeloma

Bone Marrow Transplantation
TransplantationHematology
2015English

Prospective Molecular Monitoring of Minimal Residual Disease After Non-Myeloablative Allografting in Newly Diagnosed Multiple Myeloma

Blood
BiochemistryImmunologyCell BiologyHematology
2014English

Diabetes Mellitus Increases the Risk of Intrahepatic Recurrence of Hepatocellular Carcinoma After Surgical Resection

Tumori
MedicineCancer ResearchOncology
2017English

Evaluation of MicroRNA Expression Profiles That May Predict Recurrence of Localized Stage I Non-Small Cell Lung Cancer After Surgical Resection

Cancer Research
Cancer ResearchOncology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy